ANGELA SOLTERO: Open Payments
NPI 1366830044 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 26 payments from 11 companies in 2025. Trend: 2023 $715 · 2024 $583 · 2025 $634
Food & beverage: $600Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $217 |
| Amgen Inc. | 6 | $116 |
| CSL Behring | 2 | $59 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Optinose US, Inc. | 1 | $28 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| BioCryst US Sales Co., LLC | 1 | $20 |
Products named: AIRSUPRA, TEZSPIRE, Andembry, NUCALA, Xhance, Sajazir, NEFFY, ORLADEYO.
Industry payments across KY — which companies pay providers there.
